ICAM1 and T-cell non-Hodgkin lymphoma: Blockade of ICAM-1 also inhibited the phagocytosis of live T cell lymphoma (EL4) but not other cell types such as myeloma (NSO) by stimulated macrophages (Fig. S2b).